Silver Book Fact

Multifocal electroretinogram (mFERG) and flicker perimetry show abnormal function in the central macula in early ag-related macular degeneration (AMD) and could enhance monitoring of the disease progression in individuals.

Gin T, Luu C, Guymer R. Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD. Invest Opthalmol Vis Sci. 2011; 52(12): 9267-9274. https://iovs.arvojournals.org/article.aspx?articleid=2187859

Reference

Title
Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD
Publication
Invest Opthalmol Vis Sci
Publication Date
2011
Authors
Gin T, Luu C, Guymer R
Volume & Issue
Volume 52, Issue 12
Pages
9267-9274
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.  
  • Economics of DR Treatment
    Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.  
  • Macugen to treat wet age-related macular degeneration (AMD)
    A new FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)– pegaptanib sodium (Macugen)– reduced vision loss in 70% of clinical trial patients.  
  • Gene transfer process treatment for diabetic retinopathy
    A gene transfer process that produces a VEGF receptor prevents retinal vascular permeability (RVP) associated with diabetes that could have value in treating diabetic retinopathy.  
  • Increase in AMD risk for people with a high dGI
    A recent study showed that there was a 49% increase in the risk of advanced AMD for people with a dGI (dietary glycemic index) higher than the sex median (women…